Brief: Homology Medicines Provides Update On pheEDIT And juMPStart Clinical Trials

Q32 Bio

04/01/2023 21:21

Jan 4 (Reuters) - Homology Medicines Inc  FIXX.O :
    * HOMOLOGY MEDICINES PROVIDES UPDATE ON PHEEDIT AND
JUMPSTART
CLINICAL TRIALS AND ANNOUNCES EXPECTED 2023 MILESTONES,
INCLUDING INITIAL DATA READ-OUTS FROM BOTH PROGRAMS
    * HOMOLOGY MEDICINES INC - STRONG CASH POSITION WITH RUNWAY
INTO
Q4 2024
    * HOMOLOGY MEDICINES INC-PRECLINICAL DATA FROM HMI-103 GENE
EDITING PROGRAM DEMONSTRATED SIGNIFICANTLY INCREASED POTENCY IN
PKU MODEL
    * HOMOLOGY MEDICINES INC - INITIAL DATA FROM JUMPSTART TRIAL
IS
EXPECTED IN SECOND HALF OF 2023

Source text for Eikon:  ID:nGNX5KFjVv 
Further company coverage:  FIXX.O 
 ((Reuters.Briefs@thomsonreuters.com;))